Clinical Trial Update: Open Label Immunotherapy of Endometriosis [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial assessing immunotherapy for endometriosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Immunitor LLC immunotherapy

Snippet

Sponsor: Immunitor LLC | Conditions: Endometriosis | Phase 2 | Status: UNKNOWN